MedTrace Logo

Prospective Cohort Study of HIV and Zika in Infants and Pregnancy

NCT03263195 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 395

Last updated 2022-01-14

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare the incidence of Zika virus (ZIKV) infection among pregnant women with and without Human Immunodeficiency Virus (HIV) infection and to determine the risk of adverse maternal and child outcomes associated with ZIKV/HIV co-infection across clinical sites in the continental United States (U.S.), Puerto Rico (P.R.) and Brazil.

Conditions

  • HIV
  • Zika Virus
  • Pregnant Women

Sponsors & Collaborators

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH

  • National Institute of Allergy and Infectious Diseases (NIAID)

    collaborator NIH

  • Westat

    lead OTHER

Principal Investigators

  • Marisa M. Mussi-Pinhata, MD · University of Sao Paolo, Riberao Preto Medical School, Department of Pediatrics

Eligibility

Min Age
15 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-08-23
Primary Completion
2020-09-30
Completion
2020-09-30

Countries

  • United States
  • Brazil
  • Puerto Rico

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03263195 on ClinicalTrials.gov